People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DisperSol Technologies, LLC | — | Pharmaceuticals | Series B | $37.0M | $143.8M | 2018 |
James D. Mack at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James D. Mack on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Samberg | 1 | 14 |
| Dustin Smith | 1 | 6 |
| Edward Hobart | 1 | 2 |
| Edward R. Hobart | 1 | 2 |
| Shaun Kirkpatrick | 1 | 2 |
| Chris D. Brough | 1 | 1 |
| Jeffrey D. Samberg | 1 | 1 |
| Gershon D. Yaniv | 1 | 1 |
| Edward M. Rudnic, Ph.D. | 1 | 1 |
| James Mack | 1 | 1 |
| Shaun M. Kirkpatrick | 1 | 1 |
| Gershon Yaniv | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.